NewEdge Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6
Closed -$445 4307
2025
Q3
$445 Hold
6
﹤0.01% 3958
2025
Q2
$779 Hold
6
﹤0.01% 3749
2025
Q1
$956 Hold
6
﹤0.01% 3631
2024
Q4
$1.11K Hold
6
﹤0.01% 3551
2024
Q3
$1.27K Hold
6
﹤0.01% 3468
2024
Q2
$803 Sell
6
-2
-25% -$378 ﹤0.01% 3510
2024
Q1
$1.72K Hold
8
﹤0.01% 3406
2023
Q4
$1.63K Buy
8
+2
+33% +$324 ﹤0.01% 3379
2023
Q3
$1.19K Sell
6
-885
-99% -$223K ﹤0.01% 3146
2023
Q2
$289K Buy
891
+5
+0.6% +$1.43K ﹤0.01% 1464
2023
Q1
$207K Buy
886
+858
+3,064% +$217K ﹤0.01% 1531
2022
Q4
$5.54K Buy
+28
New +$5.97K ﹤0.01% 2556

Other funds holding INSP

NewEdge Advisors's INSP Position: Q4 2025 in Review

NewEdge Advisors sold out of Inspire Medical Systems (INSP) in Q4 2025, closing a stake of 6 shares — an estimated $445 sold.

NewEdge Advisors first reported a position in INSP in Q4 2022 and held it in 12 quarters. The position peaked at $289K in Q2 2023. 342 funds tracked by Wall St. Rank hold INSP as of Q4 2025.

  • NewEdge Advisors reported no remaining Inspire Medical Systems position as of Q4 2025 after selling out during the quarter.
  • NewEdge Advisors sold 6 Inspire Medical Systems shares in Q4 2025, an estimated $445.
  • NewEdge Advisors first reported a position in Inspire Medical Systems in Q4 2022 and held it in 12 quarters.
  • NewEdge Advisors's Inspire Medical Systems position peaked at $289K in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2025.

Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.